fda warning letters glp-1 compounding september 2025 telehealth crackdown highlights role of national doctor networks FDA Sends Warning Letters to

Common GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide (Byetta, Bydureon) These drugs are prescribed for: Type 2 diabetes mellitus Chronic weight management (when FDA-approved for obesity) Diagnosis Coding: Medical Necessity Is Everything Diagnosis coding drives coverage for GLP-1 medications

Your primary care physician, family members, and friends are all great resources to help find a reputable weight loss doctor in your area

Gene expression changes initiated by GHK-CU persist beyond the treatment period

When your liver metabolizes alcohol, it produces free radicals, increasing oxidative stress, impacting liver function, including the ability to produce more glutathione, and depleting overall stores in the body

Because compounded versions are not FDA-approved, they are typically not covered by insurance

If you are investing in sleep optimization through peptides, minimizing alcohol consumption, especially in the hours before bed, will significantly improve your outcomes